MODAFIN (Provigil) ALPHA PHARMA

£108.00

Buy MODAFIN modafinil from Alpha Pharma for cognitive research applications. Lab-grade quality for in-vitro studies investigating wakefulness pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
MODAFIN (Provigil) ALPHA PHARMA
MODAFIN (Provigil) ALPHA PHARMA
£108.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: MODAFIN Modafinil by Alpha Pharma

MODAFIN is a research-grade modafinil preparation manufactured by Alpha Pharma for laboratory investigation of wakefulness and cognitive enhancement mechanisms. Modafinil is a eugeroic compound that has been extensively studied for its effects on dopamine transporter inhibition and histamine pathway modulation in preclinical models. This pharmaceutical-grade preparation enables researchers to examine the compound’s unique pharmacological profile, which differs significantly from traditional stimulant mechanisms. The compound’s selective action on specific neurotransmitter systems makes it valuable for studying sleep-wake cycle regulation, attention mechanisms, and cognitive performance pathways. Research applications span from basic neuroscience investigations to complex behavioural studies examining executive function and working memory processes.

Scientists investigating cognitive enhancement compounds will find comprehensive research support available through Stroid UK Shop, alongside our extensive collection of research chemicals including SARMs and peptides. Our modafinil research materials complement studies examining neuroplasticity, synaptic function, and neurotransmitter balance, providing researchers with reliable tools for advancing understanding of cognitive enhancement mechanisms.

Laboratory Applications and Research Protocols

MODAFIN enables sophisticated research into dopamine transporter mechanisms and their role in maintaining wakefulness without traditional stimulant-associated side effects observed in animal models. Studies have demonstrated modafinil’s unique ability to influence dopamine reuptake in specific brain regions while maintaining minimal impact on norepinephrine and serotonin systems. Research protocols commonly investigate the compound’s effects on histamine release, orexin pathway activation, and GABA-mediated sleep promotion inhibition. The compound’s oral bioavailability and extended half-life make it particularly suitable for chronic administration studies examining long-term cognitive adaptation mechanisms. Researchers frequently examine modafinil’s neuroprotective properties, including its potential effects on oxidative stress reduction and neuroinflammation modulation in various experimental paradigms.

Current research directions include investigations into modafinil’s potential applications in shift work sleep disorder models, attention deficit studies, and cognitive fatigue research protocols. The compound’s unique mechanism allows researchers to study wakefulness promotion without the cardiovascular stress typically associated with traditional stimulants, making it valuable for investigating cognitive enhancement in sensitive experimental populations.

Product Specifications

MODAFIN Technical Specifications
Parameter Specification
Active Compound Modafinil
Manufacturer Alpha Pharma
CAS Number 68693-11-8
Molecular Formula C₁₅H₁₅NO₂S
Molecular Weight 273.35 g/mol
Purity Pharmaceutical grade
Storage Requirements Room temperature, dry conditions
Research Applications Cognitive enhancement, wakefulness studies

Alpha Pharma maintains stringent quality control standards ensuring consistent research outcomes. Each batch undergoes comprehensive testing to verify identity, purity, and potency specifications required for reliable laboratory investigations. Storage recommendations maintain compound stability throughout extended research programmes.

Research Compliance and Laboratory Use

MODAFIN is exclusively intended for in-vitro research and laboratory analysis within cognitive research applications. This product is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional review board requirements when conducting studies involving this compound. All investigations should follow established research methodologies and maintain proper documentation of experimental procedures and outcomes. This research chemical is intended solely for advancing scientific understanding of cognitive enhancement mechanisms and wakefulness regulation pathways through controlled laboratory experimentation.

Related